Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile-Reference-Cited by-同舟云学术

Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile

Published:2024-09-04 Issue: Volume: Page:1-10
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Ruiz Emily S¹,Brito Karina²,Karn Emily E¹,Vidimos Allison T³,Campbell Shauna R²,Wang David M¹,Siegel Jennifer J⁴,Covington Kyle R⁴,Cook Robert W⁴,Goldberg Matthew S⁴⁵,Koyfman Shlomo A²

Affiliation:

1. Department of Dermatology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

2. Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA

3. Department of Dermatology, Cleveland Clinic, Cleveland, OH 44195, USA

4. Department of Research & Development, Castle Biosciences, Inc., Friendswood, TX 77546, USA

5. Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Funder

Castle Biosciences

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14796694.2024.2390820

Reference27 articles.

1. Skin Cancer Foundation. Our new approach to a challenging skin cancer statistic. The Skin Cancer Foundation; 2021. Accessed June 14. https://www.skincancer.org/blog/our-new-approach-to-a-challenging-skin-cancer-statistic/

2. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States

3. Cutaneous Squamous Cell Carcinoma

4. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma

5. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma